What 'Clinician Champion' Actually Costs a HealthTech Company

The unpriced dependency

Open any HealthTech GTM plan and search for the phrase "clinician champion." It will appear. It will be described as a required success factor. It will almost never have a line item next to it.

This is one of the more expensive omissions in HealthTech commercial planning. The clinician champion is not free. Finding one costs weeks of pre-sales cycle. Sustaining one costs ongoing product attention that would otherwise go to roadmap. Losing one — which happens, because clinicians change jobs — costs a deal that was already booked.

The finding cost

Finding a champion is not the same as finding a buyer. The buyer is an economic decision maker. The champion is a clinician with enough operational authority to defend the purchase inside the organization and enough evangelical energy to actually use the product publicly.

That combination is rare. Most clinicians who have operational authority are too senior to actually use the product day-to-day. Most clinicians who use the product day-to-day do not have the authority to defend it. Finding the intersection is a research problem that takes weeks per account and is not solved by hitting more accounts. It is solved by understanding organizational structure inside specific health systems well enough to know who to ask for.

The sustaining cost

Once you have a champion, sustaining them is a product-management problem, not a customer-success problem. The champion needs the product to keep making them look good inside their organization. This means the champion has effective veto power over roadmap decisions that would embarrass them.

This creates a specific tension. A single champion at a marquee account can consume a disproportionate share of product roadmap for the same reasons they are valuable — they are visible, they are influential, and losing them is expensive. Founders who do not price this end up with a roadmap that is quietly being run by two or three champions across their customer base, without ever having decided that was the plan.

The losing cost

The most under-priced cost is the losing cost. Clinicians change jobs. They retire. They move to a different service line. They lose interest. When they do, the deal they defended often does not survive the transition, because the replacement clinician did not choose the product and has no ownership of it.

Health-system deals with a single champion have a terrifying half-life. The industry average is worse than most founders assume. If you have not stress-tested your renewal rate against the assumption that thirty percent of your champions will change roles inside two years, your renewal forecast is fiction.

What real champion management looks like

Real champion management looks like the following. You never rely on a single champion per account — you build a champion bench with at least two named clinicians and one non-clinical operational owner. You track champion tenure as a leading indicator of renewal risk. You have a defined playbook for what happens when a champion signals they might leave, and it is run by the CEO or CRO, not by a CS manager. You price the pre-sales and post-sales work required to sustain a champion into your CAC and your net retention model, and you do not pretend it is zero.

Most HealthTech companies do none of this. They rely on champion energy as a free input, and are surprised when the free input turns out to be the most fragile part of the whole system.